Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS3-007a oral suspension stimulation test for diagnosis of adult growth hormone deficiency
ChiCTR2500115067Phase 2Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of GS3-007 in adult onset growth hormone deficiency (AGHD) (4 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Peak concentration of growth hormone (GH) after a single GS3-007a stimulation. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
GS3-007
03
Conditions
adult onset growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on ChiCTR2500115067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115067.